Michael Pinkawa
Arzt
Geboren:
1970
Hat mitgewirkt an:
-
Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison
-
Optimierung der perkutanen Radiotherapie und der Brachytherapie bei der Behandlung des Prostatakarzinoms
-
Long-term prognostic significance of rising PSA levels following radiotherapy for localized prostate cancer - focus on overall survival
-
Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer--predictive factors on irritative symptoms, incontinence and rectal bleeding